This is not the most recent version of the article. View current version (15 FEB 2012)

Intervention Review

Bisphosphonates for breast cancer

  1. Nick Pavlakis1,*,
  2. Robert L Schmidt2,
  3. Martin R Stockler3

Editorial Group: Cochrane Breast Cancer Group

Published Online: 16 JUL 2008

Assessed as up-to-date: 9 JAN 2007

DOI: 10.1002/14651858.CD003474.pub2

How to Cite

Pavlakis N, Schmidt RL, Stockler MR. Bisphosphonates for breast cancer. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD003474. DOI: 10.1002/14651858.CD003474.pub2.

Author Information

  1. 1

    Royal North Shore Hospital, Department of Medical Oncology, St Leonards, NSW, Australia

  2. 2

    Sydney University, Faculty of Medicine, Sydney, NSW, Australia

  3. 3

    University of Sydney, NHMRC Clinical Trials Centre and Sydney Cancer Centre, Camperdown, NSW, Australia

*Nick Pavlakis, Department of Medical Oncology, Royal North Shore Hospital, Pacific Highway, St Leonards, NSW, 2065, Australia. pavlakis@med.usyd.edu.au.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 16 JUL 2008

SEARCH

This is not the most recent version of the article.View current version (15 Feb 2012)

  1. Current Version

    Bisphosphonates and other bone agents for breast cancer

    Matthew HF Wong, Martin R Stockler and Nick Pavlakis

    Article first published online: 15 FEB 2012 | DOI: 10.1002/14651858.CD003474.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Bisphosphonates for breast cancer

    Nick Pavlakis, Robert L Schmidt and Martin R Stockler

    Article first published online: 16 JUL 2008 | DOI: 10.1002/14651858.CD003474.pub2

  2. Version 1

    Bisphosphonates for breast cancer

    N Pavlakis and M Stockler

    Article first published online: 18 APR 2005 | DOI: 10.1002/14651858.CD003474